A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

ClinicalTrials.gov ID: NCT03766685

Public ClinicalTrials.gov record NCT03766685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 12, 2026, 5:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Open-Label Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-Injector for the Subcutaneous Self-Injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the ability of subjects with moderate to severe chronic plaque psoriasis (PSO) to safely and effectively self-inject bimekizumab at study start and 8 weeks after training in self-injection technique using a prefilled safety syringe or an auto-injector.

Study identification

NCT ID: NCT03766685
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: UCB Biopharma SRL; Industry
Enrollment: 172 participants

Conditions and interventions

Conditions

Interventions

Bimekizumab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 19, 2018
Primary completion: Jul 13, 2020
Completion: Sep 7, 2020
Last update posted: Jul 13, 2025

2018 – 2020

United States locations

U.S. sites: 27
U.S. states: 18
U.S. cities: 26

Facility	City	State	ZIP	Site status
Dv0002 946	Phoenix	Arizona	85032	—
Dv0002 910	Bakersfield	California	93309	—
Dv0002 955	San Diego	California	92123	—
Dv0002 943	San Luis Obispo	California	93405	—
Dv0002 967	Santa Monica	California	90404	—
Dv0002 906	Boca Raton	Florida	33486	—
Dv0002 907	Miami	Florida	33144	—
Dv0002 903	Ocala	Florida	34471	—
Dv0002 936	Tampa	Florida	33624	—
Dv0002 941	Alpharetta	Georgia	30022	—
Dv0002 954	Skokie	Illinois	60077	—
Dv0002 900	West Des Moines	Iowa	50265	—
Dv0002 905	Overland Park	Kansas	66215	—
Dv0002 962	Owensboro	Kentucky	42301	—
Dv0002 922	Baton Rouge	Louisiana	70809	—
Dv0002 925	Brighton	Massachusetts	02135	—
Dv0002 917	Troy	Michigan	48084	—
Dv0002 915	St Louis	Missouri	63117	—
Dv0002 901	Portsmouth	New Hampshire	03801	—
Dv0002 908	East Windsor	New Jersey	08520	—
Dv0002 913	New York	New York	10029	—
Dv0002 963	Rochester	New York	14623	—
Dv0002 920	Portland	Oregon	97210	—
Dv0002 929	Portland	Oregon	97223	—
Dv0002 937	Johnston	Rhode Island	02919	—
Dv0002 951	Houston	Texas	77598	—
Dv0002 914	San Antonio	Texas	78213	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03766685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 13, 2025 · Synced Sep 12, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03766685 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →